Brinter Inc
Monday, February 26, 2024
Plymouth
Medical Devices
BRINTER, a first-mover US medical technology firm with 3D bioprinted universal human cartilage platform (BioMods™) for the $10B+ cartilage repair market.
Our first 510(k) Nose-BioMod™ product is estimated to be commercial in mid-2026.
Our bioengineered universal cartilage BioMods™ with regenerative medicine design eliminates the need for painful and expensive patient cartilage harvest/allografts in facial reconstruction and plastic/metal implants in the meniscus, hip, and shoulder tear treatments.
State
California
Country
United States
Website
https://www.brinter.com/
CEO/Top Company Official
CEO Tom Alapaattikoski
Lead Product in Development
Nose-BioMod™ for Nasal Reconstruction and Dorsal augmentation rhinoplasty.
Development Phase of Primary Product
Pre-Clinical
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
){kind=logo}